Skip to content
10-Q

Quarterly Report

ALDEYRA THERAPEUTICS, INC. ALDX

0001193125-25-266989

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 28, 2025 60.16M sh
Shares Diluted Q3 2025 · Sep 30, 2025 60.13M sh
Shares Diluted Q3 2025 · Sep 30, 2025 60.02M sh
Shares Diluted Q3 2025 · Sep 30, 2024 59.53M sh
Shares Diluted Q3 2025 · Sep 30, 2024 59.45M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$28.05M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$31.17M
Long Term Debt Q3 2025 · Sep 30, 2025 $0
Long Term Debt Q3 2025 · Dec 31, 2024 $15M
Short Term Debt Q3 2025 · Sep 30, 2025 $15.2M
Short Term Debt Q3 2025 · Dec 31, 2024 $31.37K
Cash And Equivalents Q3 2025 · Sep 30, 2025 $59.34M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $54.53M
Stockholders Equity Q3 2025 · Sep 30, 2025 $49.24M
Stockholders Equity Q3 2025 · Jun 30, 2025 $55.29M
Stockholders Equity Q3 2025 · Dec 31, 2024 $71M
Stockholders Equity Q3 2025 · Sep 30, 2024 $85.1M
Stockholders Equity Q3 2025 · Jun 30, 2024 $98.31M
Stockholders Equity Q3 2025 · Dec 31, 2023 $119.8M
Current Liabilities Q3 2025 · Sep 30, 2025 $28.48M
Current Liabilities Q3 2025 · Dec 31, 2024 $18.6M
Total Liabilities Q3 2025 · Sep 30, 2025 $28.56M
Total Liabilities Q3 2025 · Dec 31, 2024 $33.6M
Current Assets Q3 2025 · Sep 30, 2025 $77.46M
Current Assets Q3 2025 · Dec 31, 2024 $104.07M
Total Assets Q3 2025 · Sep 30, 2025 $77.8M
Total Assets Q3 2025 · Dec 31, 2024 $104.61M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.13
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.46
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.25
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.67
Eps Basic Q3 2025 · Sep 30, 2025 −$0.13
Eps Basic Q3 2025 · Sep 30, 2025 −$0.46
Eps Basic Q3 2025 · Sep 30, 2024 −$0.25
Eps Basic Q3 2025 · Sep 30, 2024 −$0.67
Sga Expense Q3 2025 · Sep 30, 2025 $2.57M
Sga Expense Q3 2025 · Sep 30, 2025 $7.24M
Sga Expense Q3 2025 · Sep 30, 2024 $3.7M
Sga Expense Q3 2025 · Sep 30, 2024 $9.94M
Rd Expense Q3 2025 · Sep 30, 2025 $5.43M
Rd Expense Q3 2025 · Sep 30, 2025 $21.36M
Rd Expense Q3 2025 · Sep 30, 2024 $12.44M
Rd Expense Q3 2025 · Sep 30, 2024 $33.59M
Net Income Q3 2025 · Sep 30, 2025 −$7.69M
Net Income Q3 2025 · Sep 30, 2025 −$27.39M
Net Income Q3 2025 · Sep 30, 2024 −$15.11M
Net Income Q3 2025 · Sep 30, 2024 −$40.04M
Operating Income Q3 2025 · Sep 30, 2025 −$8M
Operating Income Q3 2025 · Sep 30, 2025 −$28.6M
Operating Income Q3 2025 · Sep 30, 2024 −$16.14M
Operating Income Q3 2025 · Sep 30, 2024 −$43.54M